Jakarta, 16 December 2025 — ASIX, in collaboration with YC+, held a specialized seminar on TSH Biopsy and AI Medical Solutions at JS Luwansa Hotel. The event brought together healthcare professionals and industry practitioners to explore how emerging technologies are reshaping modern diagnostics and clinical workflows.
The seminar featured two focused sessions that bridged medical innovation and artificial intelligence. Mr. Nick Li delivered a presentation on TSH Biopsy technology, outlining its role in advancing molecular diagnostics and its growing relevance in clinical applications. His session highlighted how precision-driven diagnostic tools can improve accuracy and support better patient outcomes.
Complementing this perspective, Mr. Alvin Teo, Chief Commercial Officer of ASIX, presented on the application of AI in medical solutions. He discussed how AI-powered systems can assist doctors and medical experts by streamlining processes, enhancing data analysis, and supporting more efficient clinical decision-making. His session emphasized the practical value of AI as a supportive tool within healthcare environments.
The seminar also included a special segment by Miss Regina Inca, Miss Medical 2025, who delivered an encouraging address to the audience. She spoke on the importance of embracing technological advancements and reframing AI not as a threat, but as an opportunity to help the medical community evolve and meet future challenges with confidence.
Through this seminar, ASIX and Soon Poh provided a platform for meaningful discussion on how diagnostic technology and artificial intelligence can complement one another in modern healthcare. By bringing together perspectives from molecular diagnostics, AI-driven medical solutions, and public advocacy, the event highlighted the importance of collaboration in advancing clinical practices and supporting the medical community as it adapts to technological change.
